Eledon Pharmaceuticals, Inc. (ELDN)

Eledon Pharmaceuticals Statistics

Total Valuation

ELDN has a market cap or net worth of $105.09 million. The enterprise value is $22.13 million.

Market Cap	105.09M
Enterprise Value	22.13M

Important Dates

The next estimated earnings date is Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

ELDN has 39.66 million shares outstanding. The number of shares has increased by 97.94% in one year.

Shares Outstanding	39.66M
Shares Change (YoY)	+97.94%
Shares Change (QoQ)	+40.98%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	19.19%
Float	28.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.48

Current Ratio	14.48
Quick Ratio	13.88
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -70.71% and return on invested capital (ROIC) is -63.27%.

Return on Equity (ROE)	-70.71%
Return on Assets (ROA)	-25.80%
Return on Capital (ROIC)	-63.27%
Revenue Per Employee	n/a
Profits Per Employee	-$1.62M
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +117.21% in the last 52 weeks. The beta is 0.89, so ELDN's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+117.21%
50-Day Moving Average	2.73
200-Day Moving Average	2.21
Relative Strength Index (RSI)	50.16
Average Volume (20 Days)	56,495

Short Selling Information

The latest short interest is 117,869, so 0.30% of the outstanding shares have been sold short.

Short Interest	117,869
Short Previous Month	100,691
Short % of Shares Out	0.30%
Short % of Float	0.41%
Short Ratio (days to cover)	2.27

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-46.91M
Pretax Income	-39.85M
Net Income	-32.33M
EBITDA	n/a
EBIT	-46.91M
Earnings Per Share (EPS)	-$0.98

Balance Sheet

The company has $83.61 million in cash and $655,000 in debt, giving a net cash position of $82.96 million or $2.09 per share.

Cash & Cash Equivalents	83.61M
Total Debt	655,000
Net Cash	82.96M
Net Cash Per Share	$2.09
Equity (Book Value)	-8.50M
Book Value Per Share	-0.22
Working Capital	81.20M

Cash Flow

Operating Cash Flow	-37.90M
Capital Expenditures	n/a
Free Cash Flow	-37.90M
FCF Per Share	-$0.96

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ELDN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-97.94%
Shareholder Yield	-97.94%
Earnings Yield	-30.77%
FCF Yield	-36.06%

Analyst Forecast

The average price target for ELDN is $13.00, which is 390.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	390.57%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-12.58%

Stock Splits

The last stock split was on October 5, 2020. It was a reverse split with a ratio of 0.0555555:1.

Last Split Date	Oct 5, 2020
Split Type	Reverse
Split Ratio	0.0555555:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a